🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/02/2014 | 50,49 | 50,72 | 49,54 | 49,69 | -1,68% | 2,32% | 16.232.053 |
| 31/01/2014 | 50,87 | 51,03 | 50,34 | 50,54 | -1,01% | 1,35% | 17.071.920 |
| 30/01/2014 | 50,06 | 51,21 | 49,98 | 51,06 | +2,49% | 2,46% | 18.205.646 |
| 29/01/2014 | 50,29 | 50,42 | 49,41 | 49,82 | -1,25% | 2,01% | 20.274.713 |
| 28/01/2014 | 49,97 | 50,66 | 49,83 | 50,45 | +0,65% | 1,66% | 15.801.954 |
| 27/01/2014 | 50,44 | 51,62 | 50,12 | 50,12 | +1,06% | 2,97% | 32.490.096 |
| 24/01/2014 | 48,92 | 49,78 | 48,79 | 49,60 | +0,74% | 2,03% | 19.137.842 |
| 23/01/2014 | 48,86 | 49,38 | 48,53 | 49,24 | +0,49% | 1,74% | 16.639.934 |
| 22/01/2014 | 49,40 | 49,60 | 48,93 | 49,00 | -0,93% | 1,35% | 11.164.973 |
| 21/01/2014 | 49,65 | 49,86 | 49,34 | 49,46 | -0,23% | 1,04% | 11.565.204 |
| 17/01/2014 | 50,21 | 50,24 | 49,35 | 49,57 | -1,05% | 1,77% | 17.563.222 |
| 16/01/2014 | 49,76 | 50,55 | 49,71 | 50,10 | -0,04% | 1,69% | 8.142.541 |
| 15/01/2014 | 50,24 | 50,48 | 49,95 | 50,11 | -0,91% | 1,04% | 10.991.424 |
| 14/01/2014 | 50,12 | 50,67 | 49,78 | 50,57 | -0,23% | 1,77% | 22.207.854 |
| 13/01/2014 | 48,57 | 50,99 | 48,46 | 50,69 | +6,50% | 5,21% | 39.081.282 |
| 10/01/2014 | 47,55 | 47,78 | 47,23 | 47,60 | +0,73% | 1,14% | 8.533.969 |
| 09/01/2014 | 47,54 | 47,71 | 47,08 | 47,25 | -0,54% | 1,32% | 9.771.447 |
| 08/01/2014 | 47,81 | 47,84 | 47,33 | 47,51 | -0,64% | 1,08% | 14.353.094 |
| 07/01/2014 | 47,67 | 48,09 | 47,65 | 47,81 | +0,74% | 0,92% | 10.475.598 |
| 06/01/2014 | 47,53 | 47,84 | 47,24 | 47,46 | +0,02% | 1,26% | 10.408.107 |
| 03/01/2014 | 47,22 | 47,71 | 47,19 | 47,45 | +0,48% | 1,09% | 6.743.880 |
| 02/01/2014 | 47,60 | 47,75 | 47,04 | 47,22 | -1,12% | 1,48% | 8.265.052 |
| 31/12/2013 | 47,46 | 47,79 | 47,26 | 47,76 | +0,22% | 1,11% | 8.881.695 |
| 30/12/2013 | 47,46 | 47,65 | 47,07 | 47,65 | +0,30% | 1,23% | 6.625.351 |
| 27/12/2013 | 47,49 | 47,61 | 47,26 | 47,51 | +0,14% | 0,74% | 4.448.026 |
| 26/12/2013 | 47,18 | 47,47 | 47,10 | 47,44 | +0,63% | 0,79% | 5.313.150 |
| 24/12/2013 | 47,17 | 47,40 | 46,98 | 47,15 | +0,10% | 0,89% | 4.457.039 |
| 23/12/2013 | 47,18 | 47,42 | 46,99 | 47,10 | +0,08% | 0,91% | 8.660.567 |
| 20/12/2013 | 46,62 | 47,19 | 46,40 | 47,06 | +1,09% | 1,68% | 17.611.745 |
| 19/12/2013 | 46,52 | 46,71 | 46,31 | 46,56 | -0,23% | 0,86% | 9.182.995 |